Immune status could determine efficacy of COVID-19 therapies
Immune status could determine efficacy of COVID-19 therapies
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Emerging evidence suggests that SARS-CoV-2 can drive a diverse array of immune processes, raising the risk that immunosuppressant agents that are in clinical trials might be effective for some patients but detrimental for others.
Emerging evidence suggests that SARS-CoV-2 can drive a diverse array of immune processes, raising the risk that immun...
Alternative Titles
Full title
Immune status could determine efficacy of COVID-19 therapies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2414411692
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2414411692
Other Identifiers
ISSN
1474-1776
E-ISSN
1474-1784
DOI
10.1038/d41573-020-00110-3
